News
Here's the lowdown from allergy doctors on how to get relief, from which medicines to use — and how to best use them — to ...
Subjects were excluded if they had used nasal decongestants within the last ... illicit drugs using DSM-IV-R criteria. Because the Vicks ® Inhaler is an OTC product, prior experience with ...
He tested positive for methamphetamine, but insisted that the sample was the result of him using a Vicks nasal inhaler. Baxter wants the IOC to acknowledge the difference between dextro ...
While people often use Vicks VapoRub to ease congestion, it has none of the properties of a decongestant. Decongestants work by narrowing the blood vessels in nasal passages, reducing swelling and ...
Lung experts have said most patients can change to less harmful inhalers without any consequences. Some four million aerosol inhalers are prescribed in the Netherlands each year to a million and a ...
Nucala is prescribed for chronic rhinosinusitis with nasal polyps in adults ... you’ll also be prescribed a rescue inhaler to treat asthma attacks. You should not use Nucala to treat an asthma ...
Treating Severe Uncontrolled Asthma: Can Single-Inhaler, Fixed Triple-Dose Therapy Improve Outcomes?
A recently approved triple-therapy combination — fluticasone furoate, umeclidinium, and vilanterol (FF+UMEC+VI) — in a single inhaler was found to be associated with improved asthma control in ...
The study is published in Nature Communications. During the early COVID-19 pandemic, this platform enabled the rapid development of a nasal spray vaccine in collaboration with mainland China's ...
The nasal bones are two wedged-shaped bones that make up the bridge of your nose. They come together at a rigid fibrous joint, forming the thickest part of the nose. Trauma to the face often involves ...
Clinical question: Is high-flow nasal cannula oxygen therapy (HFNC) non-inferior to non-invasive ventilation (NIV) for acute exacerbations of chronic obstructive pulmonary disease (AECOPD) in patients ...
As part of an ongoing expansion strategy around the globe, Chiesi announced this week that it will invest 430 million euros (roughly $464 million) to build a new facility for inhalers and other ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results